Latest News

Wondering if Hubbell at around US$477.97 is priced for perfection or still leaves room on the table? This article walks through the numbers so you can judge whether the current tag feels stretched or reasonable. The stock has seen a 2.6% decline over the past week and a 5.6% decline over the last 30 days, while still sitting on a 44.6% 1 year return and a 172.8% return over 5 years. That mix of recent pullback and longer term strength raises fair questions about where value stands...

Harley-Davidson CEO and a company director recently purchased additional NYSE:HOG shares. Director Lori Flees made a sizeable insider purchase, increasing her personal stake in the company. These transactions add a fresh data point on insider sentiment at a time when the share price is around $18.2. For investors watching Harley-Davidson, the insider buying comes after a tough stretch for NYSE:HOG, with the stock down 6.5% over the past week and 9.6% over the past month. Returns are also...

C.H. Robinson Worldwide (NasdaqGS:CHRW) has publicly detailed the scale of its proprietary logistics dataset, which now feeds over 100 trillion real world data points into its Lean AI system. The expanded AI platform coordinates hundreds of AI agents that support millions of shipping decisions across global freight and logistics operations. The company reports measurable benefits for customers, including faster time to market and more consistent pickup performance. C.H. Robinson is putting...

If you are looking at Coupang and wondering whether the current share price reflects its true worth, you are not alone. Many investors are asking the same question. Coupang's share price closed at US$18.77 most recently, with returns of a 1.7% decline over the last 7 days, a 1.2% gain over 30 days, a 19.7% decline year to date and a 15.7% decline over 1 year, while the 3 year return sits at 45.4% and the 5 year return at a 56.6% decline. Recent coverage around Coupang has focused on its...

What the MetsäBoard Pro FBB Go launch could mean for HLSE:METSB investors Metsä Board Oyj (HLSE:METSB) has introduced MetsäBoard Pro FBB Go, a fresh fibre folding boxboard aimed at European food and pharmaceutical packaging, alongside faster custom cut sheet delivery services for regional customers. The new grade is produced at the Husum mill in Sweden and sheeted in the Netherlands, with Metsä Board highlighting short, predictable lead times and services that target deliveries in less than...

Wondering whether Capricor Therapeutics at around US$33.57 is still offering value or has already priced in the story? This article will walk you through what the numbers are actually saying about the stock. The share price has been volatile, with returns of 31.6% over the past week, 33.3% over the past month, 18.6% year to date, and 156.8% over the last year, alongside a very large 3 year gain and a more than 5x gain over 5 years. Recent interest in Capricor Therapeutics has been shaped by...

Australian Strategic Materials (ASX:ASM) has just posted its H1 2026 scorecard, with trailing 12 month revenue of A$10.1 million and a net loss of A$21.6 million, translating to a basic EPS loss of A$0.11. Over recent half year periods the company has seen revenue move from A$1.96 million in H2 2024 to A$2.20 million in H1 2025 and A$2.89 million in H2 2025, while basic EPS losses shifted from A$0.10 to A$0.08 and then A$0.06, setting up a results story where investors are weighing growing...

Denison Mines has approved the final investment decision for its Phoenix in situ recovery uranium mine. The company has started site preparation and construction work at Phoenix following this decision. Denison received a federal construction licence from the Canadian Nuclear Safety Commission, the first of its kind for a Canadian uranium mine in over 20 years. A major construction management contract has been awarded to a leading engineering firm to oversee project delivery. For investors...

Evotec (XTRA:EVT) has drawn fresh attention after beating its full-year 2025 revenue expectations and unveiling its Horizon transformation plan, a new mid term framework aimed at refocusing drug discovery and development efforts. See our latest analysis for Evotec. Despite the Horizon announcement and revenue beat, sentiment has been weak, with a 30 day share price return of 30.19% decline and a 1 year total shareholder return of 29.86% loss, indicating fading momentum. If this shift in...

Why Swire Pacific’s Latest Earnings Are Drawing Investor Attention Swire Pacific (SEHK:19) has released its full year 2025 results, with sales of HK$90,467 million compared to HK$81,969 million a year earlier, while net income was HK$2,938 million versus HK$4,321 million. This mix of higher sales and lower profit is central to how investors may be reassessing the stock today, as it raises questions about cost pressures, business mix and earnings quality across the group’s divisions. See our...

Recent trading in Sila Realty Trust (SILA) has been influenced by Truist Securities maintaining a positive view after the latest quarterly update, where earnings per share missed expectations but revenue came in slightly ahead of forecasts. See our latest analysis for Sila Realty Trust. At a share price of US$25.03, Sila Realty Trust has seen a 1-day share price return of 1.38% and a 90-day share price return of 11.05%. Its 1-year total shareholder return of 5.07% and 3-year total shareholder...

Mosaic (NYSE:MOS) has entered a joint agreement with Rainbow Rare Earths to advance the Uberaba rare earths project in Brazil. The partners plan to process phosphogypsum, a fertilizer byproduct, to produce rare earths such as neodymium and praseodymium. The initiative expands Mosaic’s business focus beyond fertilizers into materials used in clean energy and high tech applications. Mosaic, trading at $29.15, is better known for its fertilizers, so this rare earths move gives investors a...

If you are wondering whether Hochschild Mining is still good value after a strong run, this article will walk through what the current share price might be implying. The stock has had a mixed short term patch, with a 13.3% decline over the last 7 days and a 7.6% decline over 30 days. It still shows a 32.7% gain year to date and a 202.9% return over the past year, alongside a very large 3 year return and a 236.1% return over 5 years. Recent coverage has highlighted the scale of Hochschild...

Toyota Tsusho Corporation recently held a board meeting on March 3, 2026, approving an absorption-type company split that transfers part of its Sustainable Materials business to Toyotsu Chemiplas Corporation, following an earlier January 14, 2026 meeting to consider the purchase price in a repurchase tender offer. This reshaping of the Sustainable Materials portfolio highlights how Toyota Tsusho is actively reconfiguring its operations to refine focus within its broader chemicals and...

Elsight (ASX:ELS) is back on investor radars after securing a US$21.2 million contract with a European defence drone manufacturer. This development is supported by new senior hires and early deliveries of its Aura communications device. See our latest analysis for Elsight. The contract news and senior hires come after a strong run in Elsight’s shares, with a 49.5% 30 day share price return and a 1 year total shareholder return that is well into double digit multiples. This indicates strong...

Valvoline (NYSE:VVV) has launched the Happy to Help Fund in partnership with Blue Grass Community Foundation to back mental and physical well-being projects for children and youth in Lexington. The company has named Jordan M. Denny as Chief Accounting Officer and Controller, marking a key update to its executive leadership team. For you as an investor, this pairs a fresh community initiative with a leadership change at a company best known for vehicle lubricants, services, and related...

In recent days, Coca-Cola Consolidated, the largest Coca-Cola bottler in the US, reached new all-time stock highs following 16 consecutive years of positive revenue growth. This performance highlights how a steady, low-beta bottling business serving 60 million consumers across 14 states can attract considerable investor attention. We’ll now examine how Coca-Cola Consolidated’s 16-year revenue growth streak shapes its investment narrative for current and prospective shareholders. Capitalize...

Immunic (IMUX) is back on investors’ radar after proposing a reverse stock split ahead of an April 14 special shareholder meeting, while management prepares to speak at the Leerink Global Healthcare Conference on March 11. See our latest analysis for Immunic. Those recent corporate updates have come alongside sharp share price moves, with a 1 day share price return of 12.4% and a 30 day share price return of 103.08% contributing to a year to date share price return of 148.71%. However, the 5...

If you are wondering whether Textron's current share price lines up with its underlying worth, this article will walk you through what the numbers are saying and where valuation questions remain. Textron closed at US$93.27, with returns of a 6.1% decline over 7 days, a 2.3% decline over 30 days, 7.1% year to date, 28.4% over 1 year, 41.4% over 3 years, and 69.1% over 5 years. Together, these figures provide context for judging today's price tag. Recent news coverage has focused on Textron's...

In early March 2026, PACS Group, Inc. appointed Patrick H. Conway, MD, MSc, the CEO of Optum and former senior CMS leader, to its Board of Directors, adding a rare mix of clinical, regulatory, and large-scale health system leadership to its governance. This move brings to PACS Group a director who helped design major U.S. value-based payment models and still practices medicine, potentially sharpening the company’s focus on quality and reimbursement innovation in post-acute and skilled...

If you are looking at Advanced Energy Industries and wondering whether the current share price really stacks up, you are not alone. This article will walk through what that price might imply about value. The stock recently closed at US$314.84, with returns of 12.8% over 30 days, 41.8% year to date and 198.4% over the past year, which can change how investors think about both upside and risk. These moves sit against a backdrop of ongoing interest in power conversion and control solutions, as...

If you are wondering whether Magnite's current share price lines up with its underlying value, you are not alone. This article focuses on what the numbers actually say about the stock. The share price closed at US$13.03, with returns of 11.7% over 30 days, a 5.8% decline over 7 days, a nearly flat 0.1% decline over 1 year, a 55.1% gain over 3 years, and a 73.4% decline over 5 years. Recent coverage around Magnite has centered on its role in the ad tech space and how investors are thinking...

Vanda Pharmaceuticals recently received a decision from the U.S. FDA granting a rare formal evidentiary public hearing to review the agency’s proposed refusal to approve a supplemental new drug application for HETLIOZ (tasimelteon) as a treatment for jet lag disorder. This hearing, which follows Vanda’s earlier legal win requiring the FDA to more fully address its clinical evidence, highlights unusually high regulatory and scientific scrutiny around expanding HETLIOZ into a large, currently...

If you are wondering whether Papa John's International is priced attractively right now, it helps to step back and look at what the recent share performance and fundamentals are really telling you. The stock closed at US$38.86 recently, with a sharp 26.1% return over the last 7 days and 11.5% over the last 30 days, while year to date the return sits at a 3.6% decline and the 1 year return is a 7.5% decline, compared to a 46.0% decline over 3 years and a 49.9% decline over 5 years. Recent...